Helmut Thomas
Director Ejecutivo en Cyclenium Pharma, Inc. .
Cargos activos de Helmut Thomas
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
Cyclenium Pharma, Inc.
 Cyclenium Pharma, Inc. Pharmaceuticals: MajorHealth Technology Cyclenium Pharma, Inc. is a privately held pharmaceutical research and development company based in Montréal, Canada. The Canadian company is focused on creating value through the progression of internal programs in oncology, infectious diseases, and inflammation/pain. Cyclenium is also providing its extensive experience and exploring its CMRT-based Quest™ screening library in risk-sharing partnerships with leading academic and research-driven non-profit organizations, as well as collaborations with innovative pharmaceutical and biotechnology companies worldwide seeking to modulate unique and difficult disease targets in diverse therapeutic areas. The company was founded by Mark L. Peterson, and the CEO is Helmut Thomas. | Director Ejecutivo | - | - |
| Director Técnico/Científico/I+D | - | - | |
| Presidente | - | - |
Historial de carrera de Helmut Thomas
Antiguos cargos conocidos de Helmut Thomas.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| OCERA THERAPEUTICS INC | Director Técnico/Científico/I+D | 01/06/2006 | - |
| Corporate Officer/Principal | 15/07/2011 | 15/07/2013 | |
Novartis Pharma NV
 Novartis Pharma NV Pharmaceuticals: MajorHealth Technology Founded in 1996, Novartis Pharma NV is a Belgian pharmaceutical company that develops medicines. The company is based in Brussels, Belgium and is a subsidiary of Novartis AG. | Director/Miembro de la Junta | - | - |
| Ciba-Geigy Corp. | Corporate Officer/Principal | 01/01/1990 | - |
LymphoSign, Inc.
 LymphoSign, Inc. BiotechnologyHealth Technology LymphoSign, Inc. develops drugs for the cancer treatment. It also develops drugs acting on signaling pathways involved in the progression of acute leukemias, lymphomas and solid tumors. The company was founded by Chaim Roifman in 2000 and is headquartered in Markham, Canada. | Director Técnico/Científico/I+D | 29/07/2009 | - |
| Corporate Officer/Principal | 01/01/2004 | 29/07/2009 |
Formación de Helmut Thomas.
| University of Hannover | Doctorate Degree |
Estadísticas
Internacional
| Estados Unidos | 3 |
| Canadá | 3 |
| Alemania | 2 |
Operativa
| Chief Tech/Sci/R&D Officer | 3 |
| Corporate Officer/Principal | 3 |
| Doctorate Degree | 1 |
Sectorial
| Health Technology | 6 |
| Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas privadas | 5 |
|---|---|
| Ciba-Geigy Corp. | Health Technology |
Ocera Therapeutics, Inc.
 Ocera Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ocera Therapeutics, Inc. manufactures pharmaceuticals products. The company was founded in 2004 and is headquartered in Hazelwood, MO. | Health Technology |
LymphoSign, Inc.
LymphoSign, Inc. BiotechnologyHealth Technology LymphoSign, Inc. develops drugs for the cancer treatment. It also develops drugs acting on signaling pathways involved in the progression of acute leukemias, lymphomas and solid tumors. The company was founded by Chaim Roifman in 2000 and is headquartered in Markham, Canada. | Health Technology |
Novartis Pharma NV
Novartis Pharma NV Pharmaceuticals: MajorHealth Technology Founded in 1996, Novartis Pharma NV is a Belgian pharmaceutical company that develops medicines. The company is based in Brussels, Belgium and is a subsidiary of Novartis AG. | Health Technology |
Cyclenium Pharma, Inc.
Cyclenium Pharma, Inc. Pharmaceuticals: MajorHealth Technology Cyclenium Pharma, Inc. is a privately held pharmaceutical research and development company based in Montréal, Canada. The Canadian company is focused on creating value through the progression of internal programs in oncology, infectious diseases, and inflammation/pain. Cyclenium is also providing its extensive experience and exploring its CMRT-based Quest™ screening library in risk-sharing partnerships with leading academic and research-driven non-profit organizations, as well as collaborations with innovative pharmaceutical and biotechnology companies worldwide seeking to modulate unique and difficult disease targets in diverse therapeutic areas. The company was founded by Mark L. Peterson, and the CEO is Helmut Thomas. | Health Technology |
- Bolsa de valores
- Insiders
- Helmut Thomas
- Experiencia